Developing a nanoparticle test for prostate cancer scoring

BACKGROUND: Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Qun, Litherland, Sally A, Sullivan, Shannon, Hallquist, Hillari, Decker, David A, Rivera-Ramirez, Inoel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337274/
https://www.ncbi.nlm.nih.gov/pubmed/22404986
http://dx.doi.org/10.1186/1479-5876-10-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337274/
https://www.ncbi.nlm.nih.gov/pubmed/22404986
http://dx.doi.org/10.1186/1479-5876-10-44

Ejemplares similares